Language selection

Government of Canada / Gouvernement du Canada

Search

Salmonella vector (L-12259) .: NR16-176/2017E-PDF

“Promising approaches for delivering antigens and generating a protective response against cancers and infectious diseases currently employ existing vaccine strain bacteria or closely-related attenuated bacteria. Human clinical trials have shown excellent safety profiles with various recombinant vaccine strain bacteria, but generally poor efficacies for promoting immunity against the targeted diseases. Finding the right vaccine vector and antigen production system to rapidly induce an immune response while causing minimal toxicity has been challenging. To address this problem, the NRC has developed a recombinant attenuated Salmonella vaccine system capable of producing rapid cell-mediated immune protection against infectious diseases and cancers”--Highlights.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847591&sl=0

Publication information
Department/Agency
  • National Research Council Canada.
TitleSalmonella vector (L-12259) .
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Vecteur de vaccin à base de salmonelle (L-12259).
  • Caption title.
  • "December 2017."
  • Issued also in print format.
Publishing information
  • [Ottawa] : National Research Council Canada, [2018]
Description[1] p. : ill.
ISBN9780660239675
Catalogue number
  • NR16-176/2017E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: